tirzepatide type of drug F.D.A. Approves New Obesity That Will Compete With Wegovy FDA Approves Tirzepatide, A Potential

Heres whats typically required: Current BMI documentation (measured at an office visit within the past 90 days) Medical history documenting weight-related comorbidities, if your BMI is between 27 and 29.9 Evidence of a prior weight-management attempt (records from a dietitian, behavioral health provider, or structured program) A letter of medical necessity from your prescribing provider explaining why the medication is appropriate for your clinical situation Confirmation of Part D enrollment for at least 12 continuous months In our practice, our care coordination team handles the entire prior authorization process

Ese es un punto importante

Its currently in Phase III clinical trials

But it wont be for weight loss

A large cardiovascular outcomes trial (REDEFINE-3

Those who buy tirzepatide for such mechanistic studies work with concentrations ranging from picomolar to low micromolar, depending on the assay format and the desired receptor occupancy level in the experimental cell line or tissue preparation